DalsnaFinance › IPOs › Rhythm Pharmaceuticals Inc › IPO
RHYTHM PHARMACEUTICALS, INC. completed its initial public offering on NASDAQ on October 5, 2017, pricing at $17.00 a share.
| Ticker | RYTM |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 5, 2017 |
| Offering price | $17.00 |
| Shares offered | 7,050,000 |
| Total raised | $120M |
RHYTHM PHARMACEUTICALS, INC. sold 7,050,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $119.9 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $120 million total recorded for the deal.
RHYTHM PHARMACEUTICALS, INC. — quote, profile and latest news →
Source: SEC EDGAR filings for RHYTHM PHARMACEUTICALS, INC.. This page is general information, not investment advice.